Arphra/Issuer/HALO

HALO

Halozyme Therapeutics, Inc.

HealthcareBiotechnologyUSUSD

$71.69

LiveJun 04, 2026

AI Brief

Market cap

$8.5B

52w range

51.06 – 82.22

P / E

—

EPS

—

Volume

1.15M

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on Halozyme Therapeutics, Inc.’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Insider · 30d

Bought

0 txns

Sold

$3.37M

9 txns

Net flow

−$3.37M

Full history →

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$66.28

Change

-10.97%

Period high

$80.48

Period low

$62.04

Period start

$74.452026-02-02

Through 2026-06-02

Peers

No peer list available for HALO.

Price change · trailing returns

Live

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
+2.67%	+5.05%	+11.02%	+2.38%	+13.88%	+6.52%	+33.12%	+116.83%	+81.62%	+654.58%	+1586.71%

Aftermarket

Live

Jun 04, 07:20 PM

Last trade

$71.69

6 sh

Bid

$71.66

2 sh

Ask

$71.70

20 sh

Spread

$0.040

Sector & industry today

Live

Sectors

Technology
+2.80%
Utilities
+1.81%
Industrials
+1.63%
Healthcare
+1.00%
Energy
+0.92%
Basic Materials
+0.08%
Real Estate
-0.08%
Communication Services
-0.60%
Consumer Cyclical
-0.74%
Financial Services
-1.02%
Consumer Defensive
-1.60%

Top industries (issuer's industry highlighted)

Biotechnology
+1.94%
Broadcasting
+7.65%
Computer Hardware
+5.14%
Software - Infrastructure
+4.30%
Engineering & Construction
+4.05%
Semiconductors
+3.77%
Oil & Gas Drilling
+3.63%
Telecommunications Services
-3.51%
Financial - Capital Markets
+3.47%
Oil & Gas Energy
+3.01%
Beverages - Non-Alcoholic
-2.78%
Medical - Healthcare Information Services
-2.66%

Fair value

Football field →

Weighted blend

—

— vs spot

Recommendation

n/a

0 of 0 methods

Method spread

0bull0bear

±5% threshold

Analyst PT consensus: $88.25 (+23.11%)

Total assets

—

Total debt

—

Cash & equiv

—

Operating CF

—

Free cash flow

—

Buybacks

—

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Recent insiders

All →

Insider	Action	Shares	Value	Date
Torley Helen director, officer: PRESIDENT AND CEO	Sell	1,500	$101.51K	Jun 03, 2026
Torley Helen director, officer: PRESIDENT AND CEO	Sell	400	$26.55K	Jun 03, 2026
Torley Helen director, officer: PRESIDENT AND CEO	Sell	2,000	$137.47K	Jun 03, 2026
Torley Helen director, officer: PRESIDENT AND CEO	Sell	6,100	$425.12K	Jun 03, 2026
Torley Helen director, officer: PRESIDENT AND CEO	Sell	16,600	$1.1M	Jun 02, 2026
Torley Helen director, officer: PRESIDENT AND CEO	Sell	3,400	$226.93K	Jun 02, 2026

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin